Eiko Lifesciences Profit & Loss Annual

BSE: - | NSE: - | ISIN: - | Sector: -

49.23 +0.30 (0.61%)Updated : 15 Jul 2026

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Operating Expense	46.29	35.30	26.98	18.00
Other Net	0.97	0.71	0.18	0.85
Diluted Weighted Average Shares	1.41	1.30	1.03	0.96
Depreciation/ Amortization	1.02	0.74	0.66	0.63
Operating Income	6.42	2.36	0.95	0.32
Net Income	4.50	2.11	0.75	0.77
Income Availableto Com Excl Extra Ord	4.50	2.11	0.75	0.77
Other Operating Expenses Total	3.31	1.88	0.68	0.99
Net Income Before Taxes	7.12	3.06	0.98	1.03
Minority Interest	-0.83	-0.21	-	-
Net Income After Taxes	5.32	2.32	0.75	0.77
Income Availableto Com Incl Extra Ord	4.50	2.11	0.75	0.77
Costof Revenue Total	41.30	32.66	25.41	16.09
Gross Profit	11.41	5.00	2.52	2.23
Interest Inc( Exp) Net- Non- Op Total	-0.28	-0.01	-0.14	-0.15
Unusual Expense( Income)	0.00	-0.34	-	-
Diluted Net Income	4.50	2.11	0.75	0.77
Provisionfor Income Taxes	1.79	0.75	0.23	0.26
period Type	-	-	-	-
Net Income Before Extra Items	4.50	2.11	0.75	0.77
Total Revenue	52.71	37.66	27.93	18.32
period Length	12.00	12.00	12.00	12.00
Revenue	52.71	37.66	27.93	18.32
Selling/ General/ Admin Expenses Total	0.67	0.37	0.22	0.29
Diluted Normalized EPS	3.19	1.42	0.73	0.80
Diluted EPS Excluding Extra Ord Items	3.19	1.62	0.73	0.80
Total Adjustmentsto Net Income	-	-	-	0.00